The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- University of Texas at Arlington
- National Institutes of Health (R21AI126755)
This publication has 22 references indexed in Scilit:
- Initiation of sporulation inClostridium difficile: a twist on the classic modelFEMS Microbiology Letters, 2014
- Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial moleculesProceedings of the National Academy of Sciences, 2013
- Peptidoglycan transformations during Bacillus subtilis sporulationMolecular Microbiology, 2013
- The Clostridium difficile spo0A Gene Is a Persistence and Transmission FactorInfection and Immunity, 2012
- Fidaxomicin Inhibits Spore Production in Clostridium difficileClinical Infectious Diseases, 2012
- Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI StrainClinical Infectious Diseases, 2012
- Challenges of Antibacterial DiscoveryClinical Microbiology Reviews, 2011
- Spore cortex formation in Bacillus subtilis is regulated by accumulation of peptidoglycan precursors under the control of sigma KMolecular Microbiology, 2007
- Structure, Function and Dynamics in the mur Family of Bacterial Cell Wall LigasesJournal of Molecular Biology, 2006
- Localization of theBacillus subtilis murBGene within thedcwCluster Is Important for Growth and SporulationJournal of Bacteriology, 2006